FibroGen, Inc (FGEN) Total Assets by Year
FibroGen, Inc closed fiscal year 2025 with $119.6M in total assets, $149.6M in total liabilities and -$30.0M in shareholder equity. This represents a decrease of 44.3% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters FibroGen, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FGEN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $119.6M-44.3% | $214.5M-49.3% | $423.5M-30.6% | $610.1M-21.2% | $773.8M-6.4% | $826.8M-3.6% | $857.4M-2.6% | $880.6M-2.0% | $898.6M+91.4% | $469.6M-0.2% | $470.6M-2.7% | $483.5M | N/A |
| Total Liabilities | $149.6M-62.4% | $398.2M-32.0% | $585.7M-4.2% | $611.6M+12.3% | $544.7M+41.3% | $385.4M+19.7% | $322.0M-8.6% | $352.1M+0.3% | $350.9M+19.2% | $294.4M+7.6% | $273.7M+12.7% | $242.9M | N/A |
| Total Equity | -$30.0M+86.7% | -$225.6M-10.5% | -$204.2M-852.0% | -$21.4M-110.3% | $209.1M-50.5% | $422.2M-18.2% | $516.1M+1.4% | $509.2M-3.6% | $528.5M+239.1% | $155.8M-12.2% | $177.6M-19.8% | $221.4M+464.0% | -$60.8M |
FGEN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $109.6M-33.6% | $119.6M-44.3% | $137.0M-48.2% | $178.1M-39.3% | $165.2M-54.8% | $214.5M-49.3% | $264.4M-42.6% | $293.2M-43.1% | $365.9M-32.1% | $423.5M-30.6% | $460.4M-24.4% | $515.1M-25.0% |
| Total Liabilities | $153.4M-59.8% | $149.6M-62.4% | $154.0M-67.0% | $401.1M-17.1% | $382.1M-30.8% | $398.2M-32.0% | $466.1M-19.0% | $483.6M-16.0% | $552.0M-2.7% | $585.7M-4.2% | $575.6M+2.3% | $575.4M+2.2% |
| Total Equity | -$43.8M+79.8% | -$30.0M+86.7% | -$17.0M+93.0% | -$223.0M+4.0% | -$216.9M+4.9% | -$225.6M-10.5% | -$243.7M-55.0% | -$232.3M-127.2% | -$228.1M-367.0% | -$204.2M-852.0% | -$157.2M-697.5% | -$102.3M-198.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More FibroGen, Inc financials
Frequently Asked Questions
What was FibroGen, Inc's total assets in fiscal year 2025?
FibroGen, Inc closed fiscal year 2025 with $119.6M in total assets, $149.6M in total liabilities and -$30.0M in shareholder equity.
How fast is FibroGen, Inc's total assets growing?
FibroGen, Inc (FGEN) total assets fell by 44.3% year over year, from $214.5M to $119.6M in fiscal year 2025.
What was FibroGen, Inc's total assets in the most recent quarter?
FibroGen, Inc (FGEN) reported $109.6M in total assets in Q1 2026. This represents a decrease of 33.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what FibroGen, Inc (FGEN) reported on that line in every period on record.